These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 15816542

  • 21. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
    Cui W, Yu CH, Hu KQ.
    Clin Cancer Res; 2005 Nov 15; 11(22):8213-21. PubMed ID: 16299255
    [Abstract] [Full Text] [Related]

  • 22. A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts.
    Kusunoki N, Ito T, Sakurai N, Suguro T, Handa H, Kawai S.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):796-803. PubMed ID: 15870389
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells.
    Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD.
    Cancer Res; 1998 Jun 01; 58(11):2323-7. PubMed ID: 9622066
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M, Barclay C, Li AW, Geldenhuys L, Porter GA, Blay J, Casson AG, Murphy PR.
    Mol Carcinog; 2007 Dec 01; 46(12):971-80. PubMed ID: 17477358
    [Abstract] [Full Text] [Related]

  • 28. In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
    Ottanà R, Carotti S, Maccari R, Landini I, Chiricosta G, Caciagli B, Vigorita MG, Mini E.
    Bioorg Med Chem Lett; 2005 Sep 01; 15(17):3930-3. PubMed ID: 15993594
    [Abstract] [Full Text] [Related]

  • 29. Angiogenesis, cell proliferation and apoptosis in gastric ulcer healing. Effect of a selective cox-2 inhibitor.
    Sánchez-Fidalgo S, Martín-Lacave I, Illanes M, Motilva V.
    Eur J Pharmacol; 2004 Nov 28; 505(1-3):187-94. PubMed ID: 15556152
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice.
    Yao M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P, Kwong E, Evans JF, Wolfe MM.
    Cancer Res; 2003 Feb 01; 63(3):586-92. PubMed ID: 12566300
    [Abstract] [Full Text] [Related]

  • 31. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
    Chandler HL, Barden CA, Lu P, Kusewitt DF, Colitz CM.
    Mol Vis; 2007 Apr 30; 13():677-91. PubMed ID: 17563718
    [Abstract] [Full Text] [Related]

  • 32. [Effect of celecoxib on enhancing the chemotherapic sensitivity of hydroxyurea to K562 cells and its mechanism].
    Liu DS, Zhang GS.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct 30; 29(5):495-9. PubMed ID: 16137030
    [Abstract] [Full Text] [Related]

  • 33. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 30; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 34. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
    Bottone FG, Martinez JM, Alston-Mills B, Eling TE.
    Carcinogenesis; 2004 Mar 30; 25(3):349-57. PubMed ID: 14633654
    [Abstract] [Full Text] [Related]

  • 35. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N, Foderà D, D'Alessandro N, Cusimano A, Azzolina A, Tripodo C, Florena AM, Minervini MI, Notarbartolo M, Montalto G, Cervello M.
    Int J Mol Med; 2006 Feb 30; 17(2):245-52. PubMed ID: 16391822
    [Abstract] [Full Text] [Related]

  • 36. COX-2 inhibitors celecoxib and rofecoxib prevent oxidative DNA fragmentation.
    Matthias C, Schuster MT, Zieger S, Harréus U.
    Anticancer Res; 2006 Feb 30; 26(3A):2003-7. PubMed ID: 16827136
    [Abstract] [Full Text] [Related]

  • 37. Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor.
    Okumura T, Murata Y, Hizue M, Matsuura T, Naganeo R, Kanai Y, Murase A, Sakakibara A, Fujita I, Nakao K.
    Eur J Pharmacol; 2006 Jun 06; 539(1-2):125-30. PubMed ID: 16690052
    [Abstract] [Full Text] [Related]

  • 38. Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis.
    Reddy CM, Bhat VB, Kiranmai G, Reddy MN, Reddanna P, Madyastha KM.
    Biochem Biophys Res Commun; 2000 Nov 02; 277(3):599-603. PubMed ID: 11062000
    [Abstract] [Full Text] [Related]

  • 39. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
    Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G.
    J Med Chem; 2004 Jan 29; 47(3):550-7. PubMed ID: 14736236
    [Abstract] [Full Text] [Related]

  • 40. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE, Jeon NK, Kim J, Lee EJ.
    Ann N Y Acad Sci; 2007 Jan 29; 1095():99-112. PubMed ID: 17404023
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.